Verana Health Adds AI Tools and Ophthalmology Datasets
Verana Health introduced new AI tools and datasets for ophthalmology research, the company said in a press release. The products use de identified data from more than 90 million patients and will be presented at the American Academy of Ophthalmology annual meeting from October 9 to 12.
Agent Claire for Life Sciences gives researchers conversational access to disease specific patient datasets without requiring programming skills or analyst support. Its responses include the underlying query logic used to produce each answer.
Verana Health also added retinal vein occlusion and Stargardt disease datasets to its Qdata collection, along with a visual field variable for glaucoma. A collaboration with Bitfount combines AI analysis of eye scans with electronic health record criteria to identify potential clinical trial participants. Results are available through Verana Trial Connect and Bitfount's local application.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 19 Knit Health raises $35 million to roll out its healthcare world model Nov 19 Banner Health invests in Layer Health and moves its clinical registries onto its AI platform Nov 19 Half of Koreans who changed medication on AI advice had side effects, survey finds Nov 19 Isomorphic Labs and MSD team up to design cancer drugs with AI Nov 19 Boltz raises $110 million to build AI models for drug designLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Dyania Health and Nvidia bring clinical reasoning AI inside hospital networks
nference and Novo Nordisk partner on AI research into obesity, diabetes and heart disease
Unio Health Partners deploys Basata's AI agents for patient intake across 60 specialty clinics
Orakl Oncology Raises $34 Million to Predict Cancer Drug Response With AI
Banner Health invests in Layer Health and moves its clinical registries onto its AI platform
Daily AI Brief: the AI news that matters, in your inbox.